BioTraceIO Vision (V1.7)

Techsomed Medical Technologies · K251931 · 2025-09-08

BioTraceIO Vision (V1.7) is an AI-enabled medical device from Techsomed Medical Technologies, listed by FDA (510(k), K251931) with a decision date of 2025-09-08. Review panel: Radiology.

FDA submission numberK251931
Pathway510(k)
CompanyTechsomed Medical Technologies
Review panel (specialty)Radiology
FDA decision date2025-09-08
DecisionSubstantially Equivalent
Product codeQTZ
ClassificationRadiological Image Processing Software For Ablation Therapy Planning And Evaluation
Device class2
Regulation number892.2050
Review time (calendar days)76
Applicant countryIL

Official FDA database record · FDA AI-enabled device list

All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.